Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.
myTomorrows is a global platform that connects patients with unmet medical needs to treatments in development around the world.
Real Leather, Reinvented
AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
Elevara is a clinical-stage firm working on innovative therapies to treat rheumatoid arthritis and other chronic inflammatory disorders.
MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.
NanoPhoria develops non-viral, nano-delivery systems for cardiovascular treatments, focusing on inhalable biologics.
Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.
HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.
Actithera is a molecular radiotherapeutic company that develops radioligand therapies.
ENYO Pharma is a biopharmaceutical company based in Lyon, France.
GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.
SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications.
Moon Surgical develops a new category of robotic surgery that enhances existing clinical practice with collaborative and adaptive robotics.
We are making biology programmable to transform health and sustainability for the benefit of all.
DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.
Berry Street offers treatment for disordered eating, heart health, PCOD, liver disease, women's health, sports nutrition, and diabetes.
Leucid is progressing novel cart therapies that produce a better and more durable response.
Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.
Meiogenix is a biotechnology company that develops breeding technologies.
Freya Biosciences is a clinical-stage women's health company pioneering a new class of microbial immunotherapies.
Elicit Plant is an agro-biotech company thatfocuses on enhancing the resilience of crops under drought conditions through natural processes.
Prometheus Materials develops bio-cement with zero carbon emissions to reduce the global CO2 emissions.
Sofinnova Partners has invested in 150 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sofinnova Partners's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Pharmaceutical. The firm invests across 24 different industry categories.
Among tracked funding rounds, Hemab received $157.0M in a Series C round. Sofinnova Partners's total known invested capital is $7.1B.
Sofinnova Partners's average investment size is $47.4M across its portfolio of 150 companies.
Recent Sofinnova Partners portfolio additions include T-Therapeutics, myTomorrows, Qorium, AAVantgarde Bio, Hemab. These companies were founded in 2020 or later.